CATH Classification
| Level | CATH Code | Description |
|---|---|---|
|
1 | Mainly Alpha |
|
1.20 | Up-down Bundle |
|
1.20.142 | Poly(ADP-ribose) Polymerase; domain 1 |
|
1.20.142.10 | Poly(ADP-ribose) polymerase, regulatory domain |
Domain Context
CATH Clusters
| Superfamily | Poly(ADP-ribose) polymerase, regulatory domain |
| Functional Family | Poly [ADP-ribose] polymerase |
Enzyme Information
| 2.4.2.- |
Pentosyltransferases.
based on mapping to UniProt P09874
|
| 2.4.2.30 |
NAD(+) ADP-ribosyltransferase.
based on mapping to UniProt P09874
NAD(+) + (ADP-D-ribosyl)(n)-acceptor = nicotinamide + (ADP-D- ribosyl)(n+1)-acceptor.
-!- The ADP-D-ribosyl group of NAD(+) is transferred to an acceptor carboxy group on a histone or the enzyme itself, and further ADP- ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units.
|
UniProtKB Entries (1)
| P09874 |
PARP1_HUMAN
Homo sapiens
Poly [ADP-ribose] polymerase 1
|
PDB Structure
| PDB | 3L3L |
| External Links | |
| Method | X-RAY DIFFRACTION |
| Organism | |
| Primary Citation |
Discovery and SAR of substituted 3-oxoisoindoline-4-carboxamides as potent inhibitors of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer.
Bioorg.Med.Chem.Lett.
|
